HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hisataka Sakakibara Selected Research

Night Care

8/2016Caregiving activities closely associated with the development of low-back pain among female family caregivers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hisataka Sakakibara Research Topics

Disease

4Insulin Resistance
01/2022 - 01/2012
2Sleep Initiation and Maintenance Disorders (Insomnia)
11/2019 - 01/2018
2Overweight
01/2018 - 01/2012
2Body Weight (Weight, Body)
01/2018 - 01/2012
2Weight Gain
07/2014 - 11/2013
2Tobacco Use Disorder (Nicotine Dependence)
07/2014 - 11/2013
2Obesity
07/2013 - 02/2013
2Hypertension (High Blood Pressure)
02/2013 - 12/2011
2Malnutrition (Nutritional Deficiencies)
07/2010 - 11/2008
2Weight Loss (Weight Reduction)
07/2010 - 11/2008
2Hearing Loss (Hearing Impairment)
05/2003 - 02/2002
1Dementia (Dementias)
01/2017
1Substance Withdrawal Syndrome (Withdrawal Symptoms)
11/2016
1Neoplasms (Cancer)
11/2016
1Low Back Pain (Lumbago)
08/2016
1Body Weight Changes
07/2014
1Nausea
07/2014
1Fatigue
01/2014
1Ischemic Stroke
01/2013
1Occupational Stress
01/2009
1Noise-Induced Hearing Loss (Acoustic Trauma)
08/2008
1Hand-Arm Vibration Syndrome
04/2008
1Sleep Deprivation
04/2007
1Atherosclerosis
03/2006
1Stomach Neoplasms (Stomach Cancer)
07/2004
1Stroke (Strokes)
05/2004
1Coronary Disease (Coronary Heart Disease)
05/2004
1Cardiovascular Diseases (Cardiovascular Disease)
05/2004
1Thrombosis (Thrombus)
05/2004
1Ototoxicity
02/2002

Drug/Important Bio-Agent (IBA)

4Indicators and Reagents (Reagents)IBA
11/2019 - 11/2008
3Glucose (Dextrose)FDA LinkGeneric
01/2022 - 01/2012
3Insulin (Novolin)FDA Link
01/2022 - 01/2012
3C-Reactive ProteinIBA
01/2022 - 04/2007
3Hemoglobins (Hemoglobin)IBA
01/2022 - 01/2012
2HDL CholesterolIBA
01/2022 - 01/2014
2LDL CholesterolIBA
01/2022 - 01/2018
2Triglycerides (Triacylglycerol)IBA
01/2022 - 01/2018
2Varenicline (Chantix)FDA Link
07/2014 - 11/2013
2A-factor (Streptomyces)IBA
02/2013 - 01/2009
2Fibrinogen (Factor I)FDA Link
03/2006 - 05/2004
2Styrene (Styrol)IBA
05/2003 - 02/2002
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022
1oxidized low density lipoproteinIBA
01/2022
1CholesterolIBA
01/2022
1Nonesterified Fatty Acids (NEFA)IBA
01/2022
1LeptinIBA
01/2022
1AdiponectinIBA
01/2022
1LipidsIBA
06/2021
1A 7 (A-7)IBA
01/2018
1CarbohydratesIBA
02/2013
1SaltsIBA
02/2013
1Blood Glucose (Blood Sugar)IBA
04/2012
1Antihypertensive Agents (Antihypertensives)IBA
12/2011
1Prealbumin (Transthyretin)IBA
07/2010
1Blood Proteins (Serum Proteins)IBA
11/2008
1Complementary DNA (cDNA)IBA
04/2008
1Interleukin-6 (Interleukin 6)IBA
04/2007
1Anti-Bacterial Agents (Antibiotics)IBA
07/2004

Therapy/Procedure

2Therapeutics
07/2014 - 11/2013
1Home Nursing (Nursing, Home)
01/2017
1Terminal Care (Care, Terminal)
11/2016
1Night Care
08/2016
1Tobacco Use Cessation Devices
07/2014
1Secondary Prevention
01/2013
1Ear Protective Devices (Earplug)
08/2008